[August 21st, 2020 Shanghai] YAFO Life Science, along with our partners, has successfully organized the largest online corporate access event between China and Western biopharma industry on July 31st. We helped 29 overseas companies from 8 countries covering America, Asia, Europe, and China efficiently present their assets online in front of hundreds of big pharmaceutical companies in China.

SUMMER EVENT HIGHLIGHTS

● Presenting Companies: 29 companies from 8 countries.

● Total audience: 1261 viewers for presenting companies. 

● Follow-up meetings: 500+ requests for asset presenting opportunities. 

● Assets: 90+ assets looking for China or global partnering or funding.

Summer Event Presenting Companies

We would like to thank the following presenters who gave impressive presentations on our summer event.

Mr. Steven Yatomi-Clarke, the CEO of Prescient Therapeutics

Mr. Russ Havranek, the VP of Plus Therapeutics

Mr, John McGonigle, the BD Director of NuvOx Pharma

Dr. Rashida Karmali, the CEO of Tactical Therapeutics

Mrs. Ping Rawson, the CFO of Dyadic International

Mr. Morris Smith, the VP of Partnerships & Product of Lumasonix Inc.

Dr. Anton Neschadim, the CEO of ImmunoBiochem

Mrs. Susan Graf, the CEO of Akamara Therapeutics

Dr. Today Su, the CEO of Golden Biotechnology Corporation

Mr. Daniel Ring, the VP of BD & Strategic Planning of Soligenix, Inc.

Mrs. Eva Tan, the Director of Corporate & Commercial Strategy of IX Biopharma, Ltd.

Mr. Pierluigi Paracchi, the CEO of Genenta Science

Mr. David Baker, the CEO of Vallon Pharmaceuticals

Jens Schwamborn, the CEO of Organo Therapeutics

Michael Forrest, the Founder of Biophysical Therapeutics

Giuseppe D'ippolito, the CEO of IVIS Technologies

Thomas Han, the CEO of Peroxitech

SAVE THE DATE-September 24th-25th,2020 AUTUMN EVENT

This Autumn, partnering with China Pharma & Medtech BD Summit, ACCESS CHINA Forum will bring western biopharma companies efficiently present their assets not only online but also in front of 500+ healthcare companies and VCs on site. 500+ BDs from top pharma companies and VCs will participate the convention on site and more companies will join from online. During the event, audience can have access to innovative biopharma and healthcare products from China, Europe, US & Asia.

ABOUT ACCESS CHINA: The most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. Access China creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations.

ABOUT YAFO Life Science: The investment banking division of YAFO Capital with a focus on global biopharma licensing, financing, and M&A, representing leading healthcare clients from the U.S., Europe, Israel, and Asia. YAFO Life Science is dedicated to bringing global pharmaceutical and medical device products to China.

Partial Audience of ACCESS CHINA Forum